• Halozyme Therapeutics average pre-tax profit margin for 2024 was 49.69%, a 30.32% increase from 2023.
• Halozyme Therapeutics average pre-tax profit margin for 2023 was 38.13%, a 19.06% increase from 2022.
• Halozyme Therapeutics average pre-tax profit margin for 2022 was 47.11%, a 13.84% decline from 2021.

Pre-tax profit margin can be defined as earnings before taxes as a portion of total revenue.